Overview

Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme Syndrome

Status:
Terminated
Trial end date:
2017-01-16
Target enrollment:
Participant gender:
Summary
This study will investigate (a) neural and immune mechanisms underlying chronic pain in PTLS by comparing a group of PTLS patients and healthy participants on brain imaging, sensory, and immune markers; and (b) assess change in pain, brain imaging (fMRI and MRS), sensory, and immune markers in response to a combination of SNRI and glutamatergic treatment for chronic pain in PTLS (Milnacipran and D-cycloserine).
Phase:
N/A
Details
Lead Sponsor:
New York State Psychiatric Institute
Research Foundation for Mental Hygiene, Inc.
Treatments:
Cycloserine
Levomilnacipran
Milnacipran